BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/21/2024 6:02:59 AM | Browse: 80 | Download: 0
Publication Name World Journal of Gastrointestinal Surgery
Manuscript ID 90990
Country China
Category Surgery
Manuscript Type Retrospective Cohort Study
Article Title Comparison of prognosis and postoperative morbidities between standard pancreaticoduodenectomy and the TRIANGLE technique for resectable pancreatic ductal adenocarcinoma
Manuscript Source Invited Manuscript
All Author List He-Xing Hang, Zheng-Hua Cai, Yi-Fei Yang, Xu Fu, Yu-Dong Qiu and Hao Cheng
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China No. 31971518
Corresponding Author Yu-Dong Qiu, Doctor, MD, PhD, Chief Physician, Professor, Division of Pancreatic Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Medical School, Nanjing University, No. 321 Zhongshan Road, Nanjing 210008, Jiangsu Province, China. yudongqiunj@163.com
Key Words Pancreatic ductal adenocarcinoma; TRIANGLE technique; Pancreaticoduodenectomy; Prognosis; Postoperative morbidities
Core Tip We compared the prognosis and postoperative morbidities between standard pancreaticoduodenectomy (PD) and the TRIANGLE technique for resectable pancreatic ductal adenocarcinoma (PDAC). The TRIANGLE technique was safe and feasible, with acceptable postoperative complications, and improved the extent of radical resection. However, longer duration of operation, more intraoperative blood loss and higher incidence of postoperative diarrhea indicated that TRIANGLE technique was a more aggressive procedure. Local recurrence, disease-free survival and overall survival did not differ between the two groups. These results suggest that the TRIANGLE technique is not necessary for all resectable PDAC patients.
Citation Hang HX, Cai ZH, Yang YF, Fu X, Qiu YD, Cheng H. Comparison of prognosis and postoperative morbidities between standard pancreaticoduodenectomy and the TRIANGLE technique for resectable pancreatic ductal adenocarcinoma. World J Gastrointest Surg 2024; 16(3): 689-699
Received
2023-12-19 13:22
Peer-Review Started
2023-12-19 13:22
To Make the First Decision
Return for Revision
2024-01-04 13:51
Revised
2024-01-17 16:38
Second Decision
2024-02-21 02:45
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2024-02-21 06:02
Articles in Press
2024-02-21 06:02
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-03-13 03:19
ISSN 1948-9366 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com